Total Payments
$5,410
2024 Payments
$639.19
Companies
32
Transactions
350
Medicare Patients
4,546
Medicare Billing
$363,931
Payment Breakdown by Category
Food & Beverage$5,404 (99.9%)
Education$6.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,404 | 349 | 99.9% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,267 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $645.69 | 46 | $0 (2024) |
| Lilly USA, LLC | $468.70 | 27 | $0 (2024) |
| Amgen Inc. | $354.83 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $317.86 | 20 | $0 (2021) |
| GlaxoSmithKline, LLC. | $292.78 | 19 | $0 (2020) |
| PFIZER INC. | $276.43 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $226.42 | 15 | $0 (2022) |
| Allergan, Inc. | $200.97 | 12 | $0 (2020) |
| Merck Sharp & Dohme LLC | $185.13 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $639.19 | 32 | Novo Nordisk Inc ($221.75) |
| 2023 | $385.77 | 19 | Novo Nordisk Inc ($115.98) |
| 2022 | $124.53 | 5 | ABBVIE INC. ($57.32) |
| 2021 | $228.59 | 14 | Lilly USA, LLC ($90.87) |
| 2020 | $459.95 | 30 | Novo Nordisk Inc ($99.29) |
| 2019 | $888.19 | 57 | Novo Nordisk Inc ($245.20) |
| 2018 | $1,168 | 80 | Novo Nordisk Inc ($242.01) |
| 2017 | $1,516 | 113 | Novo Nordisk Inc ($289.88) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 2 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Obesity | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
| 09/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Oncology | ||||||
| 08/30/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Endocrinology | ||||||
| 08/07/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Diabetes | ||||||
| 07/27/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Obesity | ||||||
| 07/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Oncology | ||||||
| 06/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 06/01/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes | ||||||
| 04/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 04/03/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| Category: Cardiovascular | ||||||
| 03/27/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,212 | 1,895 | $282,211 | $80,456 |
| 2022 | 19 | 1,045 | 1,607 | $276,944 | $83,107 |
| 2021 | 16 | 1,047 | 1,762 | $355,022 | $100,434 |
| 2020 | 19 | 1,242 | 2,217 | $422,856 | $99,933 |
Total Patients
4,546
Total Services
7,481
Medicare Billing
$363,931
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 99 | 160 | $40,000 | $300.57 | 0.8% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 14 | 14 | $770.00 | $278.74 | 36.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $540.00 | $215.28 | 39.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 14 | $350.00 | $31.50 | 9.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 172 | 462 | $161,700 | $39,816 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 118 | 118 | $35,400 | $14,717 | 41.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 119 | 242 | $50,820 | $14,662 | 28.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 17 | 90 | $14,850 | $7,066 | 47.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 73 | 73 | $7,919 | $5,362 | 67.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 17 | 20 | $7,000 | $4,122 | 58.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 17 | 17 | $3,400 | $2,031 | 59.7% |
| G0181 | Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of c | Office | 2020 | 13 | 19 | $2,713 | $1,772 | 65.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 94 | 96 | $4,320 | $1,696 | 39.3% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 73 | 74 | $4,070 | $1,414 | 34.7% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 21 | 28 | $2,660 | $1,294 | 48.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 12 | 64 | $3,584 | $1,264 | 35.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 77 | 81 | $10,125 | $1,155 | 11.4% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2020 | 20 | 23 | $2,185 | $1,141 | 52.2% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 185 | 522 | $104,260 | $1,062 | 1.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 148 | 210 | $5,040 | $626.16 | 12.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 18 | 18 | $990.00 | $352.44 | 35.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 16 | 16 | $720.00 | $282.53 | 39.2% |
| 81003 | Automated urinalysis test | Office | 2020 | 32 | 44 | $1,100 | $97.90 | 8.9% |
About Dr. Shishir Jain, M.D
Dr. Shishir Jain, M.D is a Internal Medicine healthcare provider based in Cicero, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811085822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shishir Jain, M.D has received a total of $5,410 in payments from pharmaceutical and medical device companies, with $639.19 received in 2024. These payments were reported across 350 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,404).
As a Medicare-enrolled provider, Jain has provided services to 4,546 Medicare beneficiaries, totaling 7,481 services with total Medicare billing of $363,931. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cicero, IL
- Active Since 10/11/2006
- Last Updated 06/19/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811085822
Products in Payments
- Victoza (Drug) $327.21
- XARELTO (Drug) $299.86
- FARXIGA (Drug) $262.80
- TRULICITY (Drug) $250.11
- Ozempic (Drug) $224.86
- Tresiba (Drug) $200.11
- Prolia (Biological) $159.16
- ELIQUIS (Drug) $155.43
- Wegovy (Drug) $140.13
- SYMBICORT (Drug) $136.98
- CHANTIX (Drug) $133.11
- Rybelsus (Drug) $129.31
- SOLIQUA (Drug) $122.13
- BYDUREON (Drug) $117.81
- Trintellix (Drug) $117.11
- Saxenda (Drug) $114.35
- QULIPTA (Drug) $109.00
- ENTRESTO (Drug) $107.39
- Aimovig (Biological) $104.96
- TRELEGY ELLIPTA (Drug) $97.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cicero
Dr. Manish Desai, D.o, D.O
Internal Medicine — Payments: $10,124
Internal Medicine $10,124
Dr. Sabiha Thaseen, M.d, M.D
Internal Medicine — Payments: $67.46
Internal Medicine $67.46
Dr. Ishver Desai, M.d, M.D
Internal Medicine — Payments: $52.97
Internal Medicine $52.97
Juan Huerta
Internal Medicine — Payments: $15.40
Internal Medicine $15.40
Deepak Leekha, Md, MD
Internal Medicine
Internal Medicine
Dr. Ramnik Gokani, M.d, M.D
Internal Medicine
Internal Medicine